CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Par Pharmaceutical Inc. v. Breckenridge Pharmaceutical Inc.

1:15-cv-01039

Overview

Case Number 1:15-cv-01039
Filing Date 2015-11-11
Status Terminated
Termination Date 2016-01-25
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Par Pharmaceutical Inc. Operating Company

Represented By

2 Attorneys Listed

James L. Higgins

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-5034

Rodney Square, 1000 North King Street

Karen L. Pascale

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Plaintiff

Breckenridge Pharmaceutical Inc. Operating Company

Represented By

4 Attorneys Listed

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Sarah M. Stensland

Email: stensland@ptslaw.com

Jeffer Ali

Email: jali@carlsoncaspers.com

Alkermes Pharma Ireland Limited NPE (University / Research)

Represented By

3 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 12 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (12): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9101540
Nanoparticulate megestrol formulations
Filed: 2004-06-29
Issued: 2015-08-11
Expired (Term Ended) +717d PTA
Expires: 2026-06-16
US9101549
Nanoparticulate megestrol formulations
Filed: 2014-11-07
Issued: 2015-08-11
Active (8.0 yrs remaining)
Expires: 2034-11-07
US9107827
Nanoparticulate megestrol formulations
Filed: 2014-11-07
Issued: 2015-08-18
Active (8.0 yrs remaining)
Expires: 2034-11-07

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+717 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Docket Entries

(25 total)
Pleading / Complaint

COMPLAINT filed against Breckenridge Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1825577.) - filed by Par Pharmaceutical Inc., Alkermes Pharma Ireland Limited. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(dmp, ) (Entered: 11/12/2015)

Entry #1 • 2015-11-11
1
Pleading / Complaint

COMPLAINT filed against Breckenridge Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1825577.) - filed by Par Pharmaceutical Inc., Alkermes Pharma Ireland Limited. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(dmp, ) (Entered: 11/12/2015)

Entry #1 • 2015-11-11
2
Pleading / Complaint

COMPLAINT filed against Breckenridge Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1825577.) - filed by Par Pharmaceutical Inc., Alkermes Pharma Ireland Limited. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(dmp, ) (Entered: 11/12/2015)

Entry #1 • 2015-11-11
2
Pleading / Complaint

COMPLAINT filed against Breckenridge Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1825577.) - filed by Par Pharmaceutical Inc., Alkermes Pharma Ireland Limited. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(dmp, ) (Entered: 11/12/2015)

Entry #1 • 2015-11-11
2
Pleading / Complaint

COMPLAINT filed against Breckenridge Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1825577.) - filed by Par Pharmaceutical Inc., Alkermes Pharma Ireland Limited. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(dmp, ) (Entered: 11/12/2015)

Entry #1 • 2015-11-11
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc